MedPath

Investigating the effect of synbiotics in professional futsal athletes

Phase 3
Conditions
Muscle damage.
Registration Number
IRCT20100123003140N23
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Male gender
Not having specific diseases such as autoimmune diseases, metabolic disorders and infectious and inflammatory diseases
People with at least 1 year of futsal sports experience
Having at least 2-3 futsal practice per week
Being a permanent member of the team and registering one's profile in the national league.
Declare agreement to participate in the plan and complete the plan's informed consent

Exclusion Criteria

Intolerance and sensitivity to synbiotics and similar products
Taking antibiotics, painkillers, acute and chronic illness, acute and chronic illness medications or other medications in the last month
Using drugs that affect lipid metabolism, such as cholesterol-lowering drugs, estrogen, progesterone, diuretics, niacin, tricyclic antidepressants, antiepileptic drugs (phenytoin, valproic acid, carbamazepine, and phenobarbital) and taking drugs that affect appetite and weight. Body, medicine to control blood sugar
having specific muscle injuries and diseases such as myopathies (muscular dystrophy diseases); Neuropathies (Charcot-Marie-Tooth disease), nerve and muscle junction diseases (congenital myasthenia syndrome), motor neuron diseases (spinal muscular atrophy), fibromyalgia, myasthenia gravis before starting the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath